🇺🇸 FDA
Patent

US 10808230

Selection methods for genetically-modified T cells

granted A61KA61K2039/5156A61K2039/5158

Quick answer

US patent 10808230 (Selection methods for genetically-modified T cells) held by The Board of Regents of the University of Texas System expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/5156, A61K2039/5158, A61K35/17, A61K38/00